Pathological Examination Market: By Type, By Application, By End-User, and Geography

Pathological Examination Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Histopathology, Cytopathology, and Molecular Pathology), By Application (Cancer, Infectious Diseases, and Genetic Disorders), By End-User (Hospitals, Diagnostic Laboratories, and Research Institutes), and Region

Pathological Examination Market size was valued at approximately US$ 263.7 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030. Pathological examination refers to the study of tissues and cells to diagnose diseases and determine their causes and effects. This market encompasses various techniques, equipment, and services used in histopathology, cytopathology, and molecular pathology.

The growth of the pathological examination market is driven by factors such as the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, rising demand for personalized medicine, and growing investments in healthcare infrastructure. For instance, the integration of artificial intelligence and digital pathology solutions has significantly improved the efficiency and accuracy of pathological examinations. However, challenges such as the high cost of advanced pathology equipment, the shortage of skilled pathologists in some regions, and concerns about the standardisation of pathology practices may hinder market growth to some extent.

Pathological Examination Market Key Developments:
  • On May 1, 2024, Quest Diagnostics, a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.

Pathological Examination Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.1%

Largest Market

North-America

Fastest Growing Market

North-America

Pathological Examination Market Dynamics

The pathological examination market is primarily driven by the rising incidence of chronic diseases and disorders, including chronic lung diseases, cardiac diseases, cancer, type 2 diabetes, and stroke, as well as the increasing global mortality rates associated with these conditions. The emergence of infectious diseases such as COVID-19 has heightened the need for accurate diagnosis and treatment, further propelling market growth. Pathological examinations are extensively utilized in healthcare for disease diagnosis, treatment determination, and aiding medical professionals in providing optimal treatment options. The market is also influenced by the increasing research and development activities and higher investment in these areas. Additionally, factors such as the growing geriatric population, rising public awareness about examinations, improved healthcare infrastructure, and increased healthcare spending positively impact the pathological examination market. Moreover, the advent of digital pathology, technological advancements, and innovations offer lucrative opportunities for market players from 2024 to 2030.

Pathological Examination Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 263.7 billion

Market CAGR

3.1%

By Type

  • Histopathology
  • Cytopathology
  • Molecular Pathology

By Application

  • Cancer
  • Infectious Diseases
  • Genetic Disorders
  • Others

By End User

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutes

Key Features of the Report

  • The pathological examination market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

The global pathological examination market size was valued at approximately US$ 263.7 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030.

Key drivers include the increasing prevalence of chronic and infectious diseases, advancements in diagnostic technologies, rising demand for personalized medicine, and growing investments in healthcare infrastructure.

The main challenges include the high cost of advanced pathology equipment, the shortage of skilled pathologists in some regions, and concerns about the standardisation of pathology practices.

The key players in the pathological examination market include Roche Diagnostics, Danaher Corporation, Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, Hologic, Inc., Agilent Technologies, Becton, Dickinson and Company, Sakura Finetek Japan Co., Ltd., and Leica Biosystems (Danaher).

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Pathological Examination Market Introduction 
2.1.Global Pathological Examination Market  - Taxonomy
2.2.Global Pathological Examination Market  - Definitions
2.2.1.Type 
2.2.2.Application
2.2.3.End User
2.2.4.Region
3.Global Pathological Examination Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Pathological Examination Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Pathological Examination Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Histopathology
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Cytopathology
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Molecular Pathology
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Pathological Examination Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Cancer
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Infectious Diseases
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Genetic Disorders
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Pathological Examination Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Diagnostic Laboratories
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research Institutes
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.Global Pathological Examination Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Histopathology
9.1.2.Cytopathology
9.1.3.Molecular Pathology
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Cancer
9.2.2.Infectious Diseases
9.2.3.Genetic Disorders
9.2.4.Others
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Diagnostic Laboratories
9.3.3.Research Institutes
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Histopathology
10.1.2.Cytopathology
10.1.3.Molecular Pathology
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Cancer
10.2.2.Infectious Diseases
10.2.3.Genetic Disorders
10.2.4.Others
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Diagnostic Laboratories
10.3.3.Research Institutes
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Histopathology
11.1.2.Cytopathology
11.1.3.Molecular Pathology
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Cancer
11.2.2.Infectious Diseases
11.2.3.Genetic Disorders
11.2.4.Others
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Diagnostic Laboratories
11.3.3.Research Institutes
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Histopathology
12.1.2.Cytopathology
12.1.3.Molecular Pathology
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Cancer
12.2.2.Infectious Diseases
12.2.3.Genetic Disorders
12.2.4.Others
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Diagnostic Laboratories
12.3.3.Research Institutes
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Pathological Examination Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Histopathology
13.1.2.Cytopathology
13.1.3.Molecular Pathology
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Cancer
13.2.2.Infectious Diseases
13.2.3.Genetic Disorders
13.2.4.Others
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Diagnostic Laboratories
13.3.3.Research Institutes
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Agilent Technologies
14.2.2.Abbott Laboratories
14.2.3.Becton, Dickinson and Company
14.2.4.Roche Diagnostics
14.2.5.Danaher Corporation
14.2.6.Thermo Fisher Scientific
14.2.7.Siemens Healthineers
14.2.8.Hologic, Inc.
14.2.9.Sakura Finetek Japan Co., Ltd.
14.2.10.Leica Biosystems (Danaher)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Agilent Technologies
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Roche Diagnostics
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Hologic, Inc.
  • Sakura Finetek Japan Co., Ltd.
  • Leica Biosystems (Danaher)

Related Industry Reports